ABSTRACT:

Cervical degenerative myelopathy (CDM) is a cervical spine condition resulting in clinical manifestations of spinal cord compression related to the chronic, non-traumatic, and progressive narrowing of the cervical spinal canal. Conventional magnetic resonance imaging (MRI) is the gold standard test to diagnose and assess the severity of CDM. However, the patient is in a neutral and static position during the MRI scan, which may devalue the dynamic factors of CDM, underestimating the risk of spinal cord injury related to cervical spine flexion and extension movements. Dynamic MRI is a promising technique to change this scenario. Therefore, the present review aims to answer the following question: “Is dynamic MRI of the cervical spine more accurate in diagnosing CDM than conventional MRI?”. We will search for studies in the MEDLINE (via PubMed), Embase, Scopus, Web of Science, LILACS, and SciELO databases. The search strategy will contain a combination of terms related to cervical myelopathy and magnetic resonance imaging. Two independent reviewers will select studies, extract data, and assess the risk of bias. The synthesis of results will be descriptive, considering the main findings of the studies about the outcomes of interest.

Keywords:
spine; magnetic resonance imaging; cervical spinal cord; compressive myelopathy.

RESUMO:

A mielopatia cervical degenerativa (MCD) é uma doença da coluna cervical com manifestações clínicas de compressão da medula espinal relacionadas ao estreitamento crônico, não traumático e progressivo do canal vertebral cervical. A ressonância magnética (RM) convencional é o exame padrão-ouro para o diagnóstico e a avaliação da gravidade da MCD. Contudo, o paciente encontra-se em posição neutra e estática durante a realização deste exame, o que pode desvalorizar os fatores dinâmicos da MCD, subestimando o risco de lesão medular relacionados aos movimentos de flexão e extensão da coluna cervical. A RM dinâmica é uma técnica promissora para modificar esse panorama. Portanto, a presente revisão tem o objetivo de responder a seguinte pergunta: “A RM dinâmica da coluna cervical é mais precisa no diagnóstico de MCD em comparação à RM convencional?” As buscas por estudos serão realizadas nas bases de dados MEDLINE (via PubMed), Embase, Scopus, Web of Science, LILACS e SciELO. A estratégia de busca conterá combinação de termos relacionados à mielopatia cervical e à ressonância magnética. Dois avaliadores independentes irão realizar a seleção dos estudos, a extração dos dados e a avaliação dos riscos de viés. A síntese dos resultados será realizada de maneira descritiva, considerando os principais achados dos estudos relacionados aos desfechos de interesse.

Palavras-chave:
coluna vertebral; imagem por ressonância magnética; medula cervical; mielopatia compressiva.

Citation: Luizari VPG, Oliveira LPR, Pontes MDS, Soeira TP, Herrero CFPS. Efficacy of Dynamic Magnetic Resonance Imaging in the Diagnosis of Degenerative Cervical Myelopathy: Systematic Review Protocol*. 59(1):e17. doi:10.1055/s-0044-1779311
Financial Support: The present research has received no specific funding from agencies in the public, commercial, or not-for-profit sectors.
Note: * Work developed at Faculdade de Medicina de Ribeirão Preto, Universidade de Sao Paulo, Ribeirão Preto, SP, Brazil.

Conflict of Interests: The authors have no conflict of interests to declare.

Received: February 26 2023; Accepted: May 05 2023
 

INTRODUCTION

The term degenerative cervical myelopathy (CDM) represents a series of signs, symptoms, and pathophysiological changes that lead to spinal cord compression in the cervical region.1 It is most common cause of spinal dysfunction.2

The clinical manifestations are diverse and result from chronic, non-traumatic, and progressive spinal canal narrowing.2 Although the role of mechanical compression in CDM is widely known, dynamic factors are also significant.3 Patients may present with paresthesia in the extremities, decreased dexterity of movements, radicular pain in the upper limb, spasticity, hyperreflexia, ataxia, sphincter dysfunctions, and paresis.4 Associated conditions, including cervical radiculopathies and arterial disorders, can complicate the diagnosis; this highlights the critical role of the physical examination in cases of clinical suspicion.5

Magnetic resonance imaging (MRI) is the gold standard test to diagnose and assess the severity of CDM. A complete spinal MRI scan is indicated to prevent other staged lesions from going unnoticed.5 Recent studies6 have suggested that, as the patient is in a neutral and static position during the test, conventional MRI may not be able to assess the dynamic factors triggered by the flexion and extension of the cervical spine,which may account for the symptoms. According to the position of the cervical spine, there are descriptions of morphological and pathological variations that only dynamic MRI may identify.7

Rationale

The clinical manifestations of CDM are often inconsistent with the findings of conventional MRI scans performed with the patient in a supine position with the neck in a neutral position.8 This limitation can delay diagnosis and favor the worsening of the disease.8 Therefore, dynamic MRI has proven to be an essential tool to identify symptoms arising only during cervical spine movements, to define the therapeutic plan, and to increase diagnostic accuracy.9,10

Hence, the present systematic review aims to synthesize the available evidence on the usefulness of dynamic MRI in diagnosing CDM compared with conventional MRI.

 

MATERIALS AND METHODS

Research Question

“Is dynamic MRI of the cervical spine more accurate in diagnosing CDM than conventional MRI?”

We defined the systematic review question according to the Population, Intervention, Comparison, and Outcome (PICO) strategy.11 The included population which will consist of subjects older than 18 years of age, of both genders, with suspected CDM. The intervention will be the performance of a cervical spine dynamic MRI to confirm the diagnostic hypothesis. The comparison will be made with the gold standard test for CDM diagnosis, that is, conventional MRI. And the evaluated outcome will be the potential use of dynamic MRI as the gold standard test to diagnose CDM instead of conventional MRI.

Eligibility Criteria

The articles selected for the systematic review will be assessed according to the eligibility criteria based on the research question: subjects of both genders, older than 18 years of age, with a suspected diagnosis of DCM, and submitted to a dynamic MRI scan of the cervical spine.

Information Sources

We will search for studies in the MEDLINE (via PubMed), Embase, Scopus, Web of Science, LILACS, and SciELO databases. To reduce the publication bias, searches will also include the gray literature on Google Scholar, ClinicalTrials. gov, and the OpenGrey platform; in addition, we will analyze the references of the retrieved studies.

Query Strategy

The search strategy will be based on CDM and dynamic MRI-related terms using the Boolean operators [AND] and [OR]. The search terms will include degenerative cervical myelopathy, cervical myelopathy, magnetic resonance imaging, dynamic magnetic resonance imaging, and MRI. There will be no restrictions regarding language or year of publication.

Two independent researchers will perform the study searches and record the results regarding the number of articles available in each database in a Microsoft Excel (Microsoft Corp., Redmond, WA, United States), version 15.29, spreadsheet.

Study Selection and Data Extraction and Registration

Two independent researchers will select the studies using the Mendeley (Elsevier, Amsterdam, The Netherlands) software. In the first selection stage, the evaluators will identify the studies by reading titles and abstracts. The second stage will correspond to the reading of the full text of the articles selected in the first stage. The final selection for the systematic review will include studies meeting the previously-defined eligibility criteria. A third researcher will solve potential disagreements by consensus.

After defining the studies that will form the base of the systematic review, the two evaluators will extract data on general information regarding the publication (year, journal, country), participants (age, gender), designs, and outcomes, also independently, using the Rayyan systematic review manager (Rayyan Systems Inc., Cambridge, MA, United States).

Analysis of the Methodological Quality of the Studies

The Revised Cochrane Risk of Bias Tool for Randomized Trials (RoB 2)12 and the Risk of Bias in Non-randomized Studies - of Interventions (ROBINS-I)13 will be used to assess the risk of bias in randomized clinical trials and observational studies respectively.

Evidence Quality Assessment

After evaluating the risk of bias, the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system will be used to determine the quality of the evidence for each outcome.14

Data Synthesis

We will descriptively synthesize the information available in the literature and write a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.15

Registration

The systematic review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO)16 database at the University of York (CRD42020221798).

Amendments

The present protocol does not represent an amendment to a previously completed or published protocol. If required, records of the protocol amendments will be made in the PROSPERO platform.16

 

REFERENCES

Nouri A, Tetreault L, Singh A, Karadimas SK, Fehlings MG. Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis. Spine 2015;40(12):E675–E693
Tu J, Vargas Castillo J, Das A, Diwan AD. Degenerative Cervical Myelopathy: Insights into Its Pathobiology and Molecular Mechanisms. J Clin Med 2021;10(06):1214
Kolcun JP, Chieng LO, Madhavan K,WangMY. The Role of Dynamic Magnetic Resonance Imaging in Cervical SpondyloticMyelopathy. Asian Spine J 2017;11(06):1008–1015
Lannon M, Kachur E. Degenerative Cervical Myelopathy: Clinical Presentation, Assessment, and Natural History. J Clin Med 2021; 10(16):3626
Williams J, D’Amore P, Redlich N, DarlowM, Suwak P, Sarkovich S, Bhandutia AK. Degenerative CervicalMyelopathy: Evaluation and Management. Orthop Clin North Am 2022;53(04):509–521
Badhiwala JH, Ahuja CS, Akbar MA,Witiw CD, Nassiri F, Furlan JC, et al. Degenerative cervical myelopathy - update and future directions. Nat Rev Neurol 2020;16(02):108–124
Zhang L, Zeitoun D, Rangel A, Lazennec JY, Catonné Y, Pascal- Moussellard H. Preoperative evaluation of the cervical spondylotic myelopathy with flexion-extension magnetic resonance imaging: about a prospective study of fifty patients. Spine 2011;36(17):E1134–E1139
Denno JJ, Meadows GR. Early diagnosis of cervical spondylotic myelopathy. A useful clinical sign. Spine 1991;16(12):1353–1355
Mackenzie WG, Dhawale AA, Demczko MM, Ditro C, Rogers KJ, Bober MB, et al. Flexion-extension cervical spine MRI in children with skeletal dysplasia: is it safe and effective? J Pediatr Orthop 2013;33(01):91–98
Tykocki T, du Plessis J,Wynne-Jones G. Analysis of Morphometric Parameters in Cervical Canal Stenosis on Neutral and Dynamic Magnetic Resonance Imaging. World Neurosurg 2018;114: e317–e322
Pollock A, Berge E. How to do a systematic review. Int J Stroke 2018;13(02):138–156
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in nonrandomised studies of interventions. BMJ 2016;355:i4919
Piggott T, Morgan RL, Cuello-Garcia CA, Santesso N, Mustafa RA, Meerpohl JJ, et al; GRADE Working Group. Grading of Recommendations Assessment, Development, and Evaluations (GRADE) notes: extremely serious, GRADE’s terminology for rating down by three levels. J Clin Epidemiol 2020;120: 116–120
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372(71): n71
PROSPEROInternational prospective register of systematic reviews. Available from: <https://www.crd.york.ac.uk/prospero/ >. [Acesso em: 05 de jan. de 2023].